CN105770538A - 一种治疗血液透析患者血管通路局部硬结的中药 - Google Patents
一种治疗血液透析患者血管通路局部硬结的中药 Download PDFInfo
- Publication number
- CN105770538A CN105770538A CN201610207862.0A CN201610207862A CN105770538A CN 105770538 A CN105770538 A CN 105770538A CN 201610207862 A CN201610207862 A CN 201610207862A CN 105770538 A CN105770538 A CN 105770538A
- Authority
- CN
- China
- Prior art keywords
- grams
- gram
- radix
- chinese medicine
- vascular access
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 39
- 230000002792 vascular Effects 0.000 title claims abstract description 16
- 238000001631 haemodialysis Methods 0.000 title claims abstract description 14
- 230000000322 hemodialysis Effects 0.000 title claims abstract description 14
- 239000004863 Frankincense Substances 0.000 claims abstract description 13
- 241000218176 Corydalis Species 0.000 claims abstract description 11
- 239000002994 raw material Substances 0.000 claims abstract description 10
- 241000628997 Flos Species 0.000 claims description 25
- 241000717739 Boswellia sacra Species 0.000 claims description 12
- 208000009146 rhinoscleroma Diseases 0.000 claims description 11
- 241001057584 Myrrha Species 0.000 claims description 10
- 239000002674 ointment Substances 0.000 claims description 10
- 239000010231 banlangen Substances 0.000 claims description 9
- 241001649190 Campsis Species 0.000 claims description 8
- 241001250596 Pleione Species 0.000 claims description 8
- 230000000694 effects Effects 0.000 abstract description 16
- 208000024891 symptom Diseases 0.000 abstract description 5
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 241000864411 Alangium platanifolium Species 0.000 abstract 1
- 235000003717 Boswellia sacra Nutrition 0.000 abstract 1
- 240000007551 Boswellia serrata Species 0.000 abstract 1
- 235000012035 Boswellia serrata Nutrition 0.000 abstract 1
- 241001649187 Campsis radicans Species 0.000 abstract 1
- 240000007311 Commiphora myrrha Species 0.000 abstract 1
- 235000006965 Commiphora myrrha Nutrition 0.000 abstract 1
- 241000241550 Cyathula Species 0.000 abstract 1
- 241000146384 Glaux Species 0.000 abstract 1
- 244000284380 Hibiscus rosa sinensis Species 0.000 abstract 1
- 235000000100 Hibiscus rosa sinensis Nutrition 0.000 abstract 1
- 241000766380 Iphigenia Species 0.000 abstract 1
- 241000334160 Isatis Species 0.000 abstract 1
- 240000003915 Lophatherum gracile Species 0.000 abstract 1
- 244000235756 Microcos paniculata Species 0.000 abstract 1
- 235000007265 Myrrhis odorata Nutrition 0.000 abstract 1
- 244000215777 Plumeria rubra Species 0.000 abstract 1
- 235000013087 Plumeria rubra Nutrition 0.000 abstract 1
- 240000000103 Potentilla erecta Species 0.000 abstract 1
- 235000016551 Potentilla erecta Nutrition 0.000 abstract 1
- 235000000664 Rosa chinensis Nutrition 0.000 abstract 1
- 235000016785 Rosa della China Nutrition 0.000 abstract 1
- 240000003705 Senecio vulgaris Species 0.000 abstract 1
- 241000219784 Sophora Species 0.000 abstract 1
- 241001078983 Tetradium ruticarpum Species 0.000 abstract 1
- 238000010521 absorption reaction Methods 0.000 abstract 1
- 230000009194 climbing Effects 0.000 abstract 1
- 230000000857 drug effect Effects 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 27
- 210000004369 blood Anatomy 0.000 description 26
- 208000002193 Pain Diseases 0.000 description 19
- 230000036407 pain Effects 0.000 description 19
- 230000017531 blood circulation Effects 0.000 description 16
- 230000001276 controlling effect Effects 0.000 description 13
- 230000002401 inhibitory effect Effects 0.000 description 13
- 229940079593 drug Drugs 0.000 description 12
- 239000003513 alkali Substances 0.000 description 10
- 230000001754 anti-pyretic effect Effects 0.000 description 10
- 239000002221 antipyretic Substances 0.000 description 10
- 235000009508 confectionery Nutrition 0.000 description 10
- 231100000614 poison Toxicity 0.000 description 10
- 230000001737 promoting effect Effects 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 229930013930 alkaloid Natural products 0.000 description 9
- 230000000202 analgesic effect Effects 0.000 description 9
- 230000008961 swelling Effects 0.000 description 9
- 241000283973 Oryctolagus cuniculus Species 0.000 description 8
- 150000003797 alkaloid derivatives Chemical class 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- 208000014674 injury Diseases 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 210000000952 spleen Anatomy 0.000 description 7
- 210000002784 stomach Anatomy 0.000 description 7
- 231100000331 toxic Toxicity 0.000 description 7
- 230000002588 toxic effect Effects 0.000 description 7
- 239000000341 volatile oil Substances 0.000 description 7
- 206010012735 Diarrhoea Diseases 0.000 description 6
- -1 Phenylpropanoid Glycosides Chemical class 0.000 description 6
- 239000003440 toxic substance Substances 0.000 description 6
- 230000008736 traumatic injury Effects 0.000 description 6
- AEQDJSLRWYMAQI-QGZVFWFLSA-N (13ar)-2,3,9,10-tetramethoxy-6,8,13,13a-tetrahydro-5h-isoquinolino[2,1-b]isoquinoline Chemical compound C1CN2CC(C(=C(OC)C=C3)OC)=C3C[C@@H]2C2=C1C=C(OC)C(OC)=C2 AEQDJSLRWYMAQI-QGZVFWFLSA-N 0.000 description 5
- 201000000736 Amenorrhea Diseases 0.000 description 5
- 206010001928 Amenorrhoea Diseases 0.000 description 5
- 208000006820 Arthralgia Diseases 0.000 description 5
- 206010007247 Carbuncle Diseases 0.000 description 5
- ZSBXGIUJOOQZMP-UHFFFAOYSA-N Isomatrine Natural products C1CCC2CN3C(=O)CCCC3C3C2N1CCC3 ZSBXGIUJOOQZMP-UHFFFAOYSA-N 0.000 description 5
- ZSBXGIUJOOQZMP-JLNYLFASSA-N Matrine Chemical compound C1CC[C@H]2CN3C(=O)CCC[C@@H]3[C@@H]3[C@H]2N1CCC3 ZSBXGIUJOOQZMP-JLNYLFASSA-N 0.000 description 5
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 5
- 208000025747 Rheumatic disease Diseases 0.000 description 5
- 206010042674 Swelling Diseases 0.000 description 5
- 231100000540 amenorrhea Toxicity 0.000 description 5
- 235000001014 amino acid Nutrition 0.000 description 5
- 150000001413 amino acids Chemical class 0.000 description 5
- VRSRXLJTYQVOHC-YEJXKQKISA-N corydaline Chemical compound C=1([C@H]2[C@H]3C)C=C(OC)C(OC)=CC=1CCN2CC1=C3C=CC(OC)=C1OC VRSRXLJTYQVOHC-YEJXKQKISA-N 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 230000003203 everyday effect Effects 0.000 description 5
- 210000003026 hypopharynx Anatomy 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 229930014456 matrine Natural products 0.000 description 5
- 244000045947 parasite Species 0.000 description 5
- 230000000552 rheumatic effect Effects 0.000 description 5
- YRAQEMCYCSSHJG-NSHDSACASA-N (S)-columbianetin Chemical compound C1=CC(=O)OC2=C1C=CC1=C2C[C@@H](C(C)(O)C)O1 YRAQEMCYCSSHJG-NSHDSACASA-N 0.000 description 4
- XVPBINOPNYFXID-JARXUMMXSA-N 85u4c366qs Chemical compound C([C@@H]1CCC[N@+]2(CCC[C@H]3[C@@H]21)[O-])N1[C@@H]3CCCC1=O XVPBINOPNYFXID-JARXUMMXSA-N 0.000 description 4
- 206010000077 Abdominal mass Diseases 0.000 description 4
- 206010000087 Abdominal pain upper Diseases 0.000 description 4
- 208000005171 Dysmenorrhea Diseases 0.000 description 4
- 206010013935 Dysmenorrhoea Diseases 0.000 description 4
- 231100000111 LD50 Toxicity 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 4
- 208000003251 Pruritus Diseases 0.000 description 4
- 241000700159 Rattus Species 0.000 description 4
- 230000008602 contraction Effects 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 230000035619 diuresis Effects 0.000 description 4
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 229930015582 oxymatrine Natural products 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 241000700199 Cavia porcellus Species 0.000 description 3
- AQASRZOCERRGBL-UHFFFAOYSA-N Dauricine Natural products CN1CCC2=CC(OC)=C(OC)C=C2C1CC1=CC=C(O)C(OC2=CC=C(C=C2)CC2N(C)CCC=3C=C(C(=CC=32)OC)OC)=C1 AQASRZOCERRGBL-UHFFFAOYSA-N 0.000 description 3
- 206010021118 Hypotonia Diseases 0.000 description 3
- VFXXNAVZODKBIW-GMBDUWKCSA-N Isoplumericin Natural products COC(=O)C1=CO[C@H]2O[C@@H]3C(=CC)C(=O)O[C@@]34C=C[C@@H]1[C@@H]24 VFXXNAVZODKBIW-GMBDUWKCSA-N 0.000 description 3
- 208000019255 Menstrual disease Diseases 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 206010035664 Pneumonia Diseases 0.000 description 3
- AAGFPTSOPGCENQ-UHFFFAOYSA-N Sophocarpin I Natural products C1CCC2CN3C(=O)C=CCC3C3C2N1CCC3 AAGFPTSOPGCENQ-UHFFFAOYSA-N 0.000 description 3
- IGXQFUGORDJEST-UHFFFAOYSA-N Sophocarpine Natural products O=C1C=CCC2C3CCCC4CCCC(CN12)C34 IGXQFUGORDJEST-UHFFFAOYSA-N 0.000 description 3
- 241000191967 Staphylococcus aureus Species 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- AQASRZOCERRGBL-ROJLCIKYSA-N dauricine Chemical compound CN1CCC2=CC(OC)=C(OC)C=C2[C@H]1CC1=CC=C(O)C(OC2=CC=C(C=C2)C[C@H]2N(C)CCC=3C=C(C(=CC=32)OC)OC)=C1 AQASRZOCERRGBL-ROJLCIKYSA-N 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 201000006549 dyspepsia Diseases 0.000 description 3
- 229930003944 flavone Natural products 0.000 description 3
- 235000011949 flavones Nutrition 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 206010022000 influenza Diseases 0.000 description 3
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 3
- 210000002429 large intestine Anatomy 0.000 description 3
- 230000005906 menstruation Effects 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 238000010926 purge Methods 0.000 description 3
- AAGFPTSOPGCENQ-JLNYLFASSA-N sophocarpine Chemical compound C1CC[C@H]2CN3C(=O)C=CC[C@@H]3[C@@H]3[C@H]2N1CCC3 AAGFPTSOPGCENQ-JLNYLFASSA-N 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 150000003648 triterpenes Chemical class 0.000 description 3
- JLTCWSBVQSZVLT-CDIPANDDSA-N (2s)-n-[(2s)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]-1-[(4r,7s,10s,13s,16s,19r)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosan Chemical compound NCCCC[C@@H](C(=O)NCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](N)CSSC1.C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 JLTCWSBVQSZVLT-CDIPANDDSA-N 0.000 description 2
- NBGQZFQREPIKMG-UHFFFAOYSA-N 3beta-hydroxy-beta-boswellic acid Natural products C1CC(O)C(C)(C(O)=O)C2CCC3(C)C4(C)CCC5(C)CCC(C)C(C)C5C4=CCC3C21C NBGQZFQREPIKMG-UHFFFAOYSA-N 0.000 description 2
- XQXPVVBIMDBYFF-UHFFFAOYSA-N 4-hydroxyphenylacetic acid Chemical compound OC(=O)CC1=CC=C(O)C=C1 XQXPVVBIMDBYFF-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Natural products CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- NWUMSRKLBRWRAS-UHFFFAOYSA-N Arundoin Natural products COC1CCC2(C)C(CCC3C2=CCC4(C)C5CC(C)(C)CCC5(C)CCC34C)C1(C)C NWUMSRKLBRWRAS-UHFFFAOYSA-N 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- NBGQZFQREPIKMG-PONOSELZSA-N Boswellic acid Chemical compound C1C[C@@H](O)[C@](C)(C(O)=O)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C NBGQZFQREPIKMG-PONOSELZSA-N 0.000 description 2
- 206010008909 Chronic Hepatitis Diseases 0.000 description 2
- VRSRXLJTYQVOHC-UHFFFAOYSA-N Corydaline Natural products CC1C2C=3C=C(OC)C(OC)=CC=3CCN2CC2=C1C=CC(OC)=C2OC VRSRXLJTYQVOHC-UHFFFAOYSA-N 0.000 description 2
- 241000846172 Cremastra appendiculata Species 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 241000282326 Felis catus Species 0.000 description 2
- 241000700721 Hepatitis B virus Species 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 235000000177 Indigofera tinctoria Nutrition 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 241000589902 Leptospira Species 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- YAPAFDNQABLIIN-UHFFFAOYSA-N N1,N10-Dicoumaroylspermidine Natural products CC(C)=CCC1=C(O)C(CC=C(C)C)=CC(C=CC(=O)C=2C(=C(CC=C(C)C)C(O)=CC=2)O)=C1 YAPAFDNQABLIIN-UHFFFAOYSA-N 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- HPUXDMUGCAWDFW-UHFFFAOYSA-N Osthole Natural products COc1ccc2CCC(=O)Oc2c1C=CC(=O)C HPUXDMUGCAWDFW-UHFFFAOYSA-N 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- VFXXNAVZODKBIW-JKXVGBJFSA-N Plumericin Chemical compound COC(=O)C([C@@H](C=C1)[C@H]23)=CO[C@@H]2O[C@@H]\2[C@]13OC(=O)C/2=C/C VFXXNAVZODKBIW-JKXVGBJFSA-N 0.000 description 2
- VFXXNAVZODKBIW-OZNWZFTHSA-N Plumericin Natural products COC(=O)C1=CO[C@H]2O[C@H]3C(=CC)C(=O)O[C@]34C=C[C@H]1[C@H]24 VFXXNAVZODKBIW-OZNWZFTHSA-N 0.000 description 2
- 102000005320 Posterior Pituitary Hormones Human genes 0.000 description 2
- 108010070873 Posterior Pituitary Hormones Proteins 0.000 description 2
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 2
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 2
- YAPAFDNQABLIIN-XNTDXEJSSA-N Sophoradin Chemical compound CC(C)=CCC1=C(O)C(CC=C(C)C)=CC(\C=C\C(=O)C=2C(=C(CC=C(C)C)C(O)=CC=2)O)=C1 YAPAFDNQABLIIN-XNTDXEJSSA-N 0.000 description 2
- RFAOSYMVZBUVLO-UHFFFAOYSA-N Sophoradin Natural products COC(=O)CCC1(C)C(CCC2(C)C1CCC3C(CCC23C)C(C)(O)CCC=C(C)C)C(=C)C RFAOSYMVZBUVLO-UHFFFAOYSA-N 0.000 description 2
- 229930182558 Sterol Natural products 0.000 description 2
- YRAQEMCYCSSHJG-UHFFFAOYSA-N Tetrahydro-oroselol Natural products C1=CC(=O)OC2=C1C=CC1=C2CC(C(C)(O)C)O1 YRAQEMCYCSSHJG-UHFFFAOYSA-N 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- UGIVASYMZSZAMP-UHFFFAOYSA-N chebulagic acid Natural products OC1C2c3c(OC1=O)c(O)c(O)cc3C(=O)OC4C(OC(=O)c5cc(O)c(O)c(O)c5)OC6COC(=O)c7cc(O)c(O)c(O)c7c8c(O)c(O)c(O)cc8C(=O)OC4C6OC(=O)C2(O)C(=O)O UGIVASYMZSZAMP-UHFFFAOYSA-N 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- VOLZBKQSLGCZGC-UHFFFAOYSA-N egonol Chemical compound C1=C2OCOC2=CC(C2=CC=3C=C(CCCO)C=C(C=3O2)OC)=C1 VOLZBKQSLGCZGC-UHFFFAOYSA-N 0.000 description 2
- 229960002694 emetine Drugs 0.000 description 2
- 206010014599 encephalitis Diseases 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 210000001105 femoral artery Anatomy 0.000 description 2
- 150000002213 flavones Chemical class 0.000 description 2
- HYBBIBNJHNGZAN-UHFFFAOYSA-N furfural Chemical compound O=CC1=CC=CO1 HYBBIBNJHNGZAN-UHFFFAOYSA-N 0.000 description 2
- 229940074391 gallic acid Drugs 0.000 description 2
- 235000004515 gallic acid Nutrition 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 238000003304 gavage Methods 0.000 description 2
- 229930182478 glucoside Natural products 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 229940097275 indigo Drugs 0.000 description 2
- COHYTHOBJLSHDF-UHFFFAOYSA-N indigo powder Natural products N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 238000002690 local anesthesia Methods 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000036640 muscle relaxation Effects 0.000 description 2
- 208000031225 myocardial ischemia Diseases 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- MBRLOUHOWLUMFF-UHFFFAOYSA-N osthole Chemical compound C1=CC(=O)OC2=C(CC=C(C)C)C(OC)=CC=C21 MBRLOUHOWLUMFF-UHFFFAOYSA-N 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 150000002989 phenols Chemical class 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- XOKSLPVRUOBDEW-UHFFFAOYSA-N pinane Chemical compound CC1CCC2C(C)(C)C1C2 XOKSLPVRUOBDEW-UHFFFAOYSA-N 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- GPTFURBXHJWNHR-UHFFFAOYSA-N protopine Chemical compound C1=C2C(=O)CC3=CC=C4OCOC4=C3CN(C)CCC2=CC2=C1OCO2 GPTFURBXHJWNHR-UHFFFAOYSA-N 0.000 description 2
- 235000005875 quercetin Nutrition 0.000 description 2
- 229960001285 quercetin Drugs 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 230000000391 smoking effect Effects 0.000 description 2
- 235000014347 soups Nutrition 0.000 description 2
- 150000003432 sterols Chemical class 0.000 description 2
- 235000003702 sterols Nutrition 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 2
- REZQBEBOWJAQKS-UHFFFAOYSA-N triacontan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO REZQBEBOWJAQKS-UHFFFAOYSA-N 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 210000004291 uterus Anatomy 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- FQTLCLSUCSAZDY-UHFFFAOYSA-N (+) E(S) nerolidol Natural products CC(C)=CCCC(C)=CCCC(C)(O)C=C FQTLCLSUCSAZDY-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 description 1
- MADYLZJCRKUBIK-RYGJVYDSSA-N (+/-)-Homochelidonine Chemical compound C([C@@H]1O)C2=CC=3OCOC=3C=C2[C@@H]2[C@H]1C1=CC=C(OC)C(OC)=C1CN2C MADYLZJCRKUBIK-RYGJVYDSSA-N 0.000 description 1
- GRWFGVWFFZKLTI-IUCAKERBSA-N (-)-α-pinene Chemical compound CC1=CC[C@@H]2C(C)(C)[C@H]1C2 GRWFGVWFFZKLTI-IUCAKERBSA-N 0.000 description 1
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 description 1
- BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 description 1
- AAWZDTNXLSGCEK-LNVDRNJUSA-N (3r,5r)-1,3,4,5-tetrahydroxycyclohexane-1-carboxylic acid Chemical compound O[C@@H]1CC(O)(C(O)=O)C[C@@H](O)C1O AAWZDTNXLSGCEK-LNVDRNJUSA-N 0.000 description 1
- IOIGOIPHPUCFOB-IMTBSYHQSA-N (6r,7s)-7-methyl-6,7-dihydro-5h-cyclopenta[c]pyridin-6-ol Chemical compound C1=NC=C2[C@H](C)[C@H](O)CC2=C1 IOIGOIPHPUCFOB-IMTBSYHQSA-N 0.000 description 1
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 1
- WUOACPNHFRMFPN-SECBINFHSA-N (S)-(-)-alpha-terpineol Chemical compound CC1=CC[C@@H](C(C)(C)O)CC1 WUOACPNHFRMFPN-SECBINFHSA-N 0.000 description 1
- MTXSIJUGVMTTMU-JTQLQIEISA-N (S)-anabasine Chemical compound N1CCCC[C@H]1C1=CC=CN=C1 MTXSIJUGVMTTMU-JTQLQIEISA-N 0.000 description 1
- GVSPXQVUXHMUMA-MDWZMJQESA-N (e)-3-(3,5-ditert-butyl-4-hydroxyphenyl)-1-(4-methoxyphenyl)prop-2-en-1-one Chemical compound C1=CC(OC)=CC=C1C(=O)\C=C\C1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 GVSPXQVUXHMUMA-MDWZMJQESA-N 0.000 description 1
- YGVHOSGNOYKRIH-UHFFFAOYSA-N 1,3,6-tri-O-galloyl-2,4-O-chebuloyl-beta-D-glucopyranose Natural products O1C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(C2OC(=O)C=3C=C(O)C(O)=C(O)C=3)OC(=O)C(C3=4)=CC(O)=C(O)C=4OC(=O)C(O)C3C(CC(O)=O)C(=O)OC2C1COC(=O)C1=CC(O)=C(O)C(O)=C1 YGVHOSGNOYKRIH-UHFFFAOYSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- VCNKUCWWHVTTBY-UHFFFAOYSA-N 18alpha-Oleanane Natural products C1CCC(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C)(C)CC5C4CCC3C21C VCNKUCWWHVTTBY-UHFFFAOYSA-N 0.000 description 1
- XYHKNCXZYYTLRG-UHFFFAOYSA-N 1h-imidazole-2-carbaldehyde Chemical compound O=CC1=NC=CN1 XYHKNCXZYYTLRG-UHFFFAOYSA-N 0.000 description 1
- NKDFYOWSKOHCCO-YPVLXUMRSA-N 20-hydroxyecdysone Chemical compound C1[C@@H](O)[C@@H](O)C[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@@](C)(O)[C@H](O)CCC(C)(O)C)CC[C@]33O)C)C3=CC(=O)[C@@H]21 NKDFYOWSKOHCCO-YPVLXUMRSA-N 0.000 description 1
- HXWZQRICWSADMH-SEHXZECUSA-N 20-hydroxyecdysone Natural products CC(C)(C)CC[C@@H](O)[C@@](C)(O)[C@H]1CC[C@@]2(O)C3=CC(=O)[C@@H]4C[C@@H](O)[C@@H](O)C[C@]4(C)[C@H]3CC[C@]12C HXWZQRICWSADMH-SEHXZECUSA-N 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-M 3-Methylbutanoic acid Natural products CC(C)CC([O-])=O GWYFCOCPABKNJV-UHFFFAOYSA-M 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- YFVGIJBUXMQFOF-PJOVQGMDSA-N 5-hydroxy-2-(4-methoxyphenyl)-7-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-4-one Chemical compound C1=CC(OC)=CC=C1C(OC1=C2)=CC(=O)C1=C(O)C=C2O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)O1 YFVGIJBUXMQFOF-PJOVQGMDSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- ZHQQRIUYLMXDPP-SSDOTTSWSA-N Actinidine Natural products C1=NC=C(C)C2=C1[C@H](C)CC2 ZHQQRIUYLMXDPP-SSDOTTSWSA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 208000006400 Arbovirus Encephalitis Diseases 0.000 description 1
- 241001480043 Arthrodermataceae Species 0.000 description 1
- MRNPHCMRIQYRFU-KXUMSINMSA-N Arundoin Chemical compound C([C@]1(C)[C@@H](C(C)C)CC[C@H]1[C@]1(C)CC=C23)C[C@]1(C)[C@H]3CC[C@@H]1[C@]2(C)CC[C@H](OC)C1(C)C MRNPHCMRIQYRFU-KXUMSINMSA-N 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 206010048962 Brain oedema Diseases 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- SGNBVLSWZMBQTH-FGAXOLDCSA-N Campesterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 SGNBVLSWZMBQTH-FGAXOLDCSA-N 0.000 description 1
- 241000282465 Canis Species 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- HGJXAVROWQLCTP-YABCKIEDSA-N Chebulagic acid Chemical compound O([C@H]1[C@H]2[C@H]3OC(=O)C4=CC(O)=C(O)C(O)=C4C4=C(O)C(O)=C(O)C=C4C(=O)OC[C@@H](O1)[C@H]3OC(=O)[C@@H](CC(O)=O)[C@@H]1[C@@H](C(OC=3C(O)=C(O)C=C(C1=3)C(=O)O2)=O)O)C(=O)C1=CC(O)=C(O)C(O)=C1 HGJXAVROWQLCTP-YABCKIEDSA-N 0.000 description 1
- 229920002052 Chebulagic acid Polymers 0.000 description 1
- YGVHOSGNOYKRIH-FJPMMHPYSA-N Chebulinic acid Chemical compound C([C@@H]1[C@H]2OC(=O)[C@@H](CC(O)=O)[C@@H]3[C@@H](C(OC=4C(O)=C(O)C=C(C3=4)C(=O)O[C@@H]([C@H](OC(=O)C=3C=C(O)C(O)=C(O)C=3)O1)[C@H]2OC(=O)C=1C=C(O)C(O)=C(O)C=1)=O)O)OC(=O)C1=CC(O)=C(O)C(O)=C1 YGVHOSGNOYKRIH-FJPMMHPYSA-N 0.000 description 1
- 229920000585 Chebulinic acid Polymers 0.000 description 1
- MHDANAFDVQLLPY-UHFFFAOYSA-N Chebulinic acid Natural products OC(C1C(CC(=O)O)C(=O)OC2C(COC(=O)c3cc(O)c(O)c(O)c3)OC(OC(=O)c4cc(O)c(O)c(O)c4)C(OC(=O)c5cc(O)c(O)c(O)c15)C2OC(=O)c6cc(O)c(O)c(O)c6)C(=O)O MHDANAFDVQLLPY-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 239000004380 Cholic acid Substances 0.000 description 1
- 206010009346 Clonus Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- AAWZDTNXLSGCEK-UHFFFAOYSA-N Cordycepinsaeure Natural products OC1CC(O)(C(O)=O)CC(O)C1O AAWZDTNXLSGCEK-UHFFFAOYSA-N 0.000 description 1
- 229920002786 Corilagin Polymers 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- MRNPHCMRIQYRFU-UWAWSDATSA-N Cylindrin Chemical compound C([C@@]1(C)[C@H](C(C)C)CC[C@@H]1[C@@]1(C)CC=C23)C[C@@]1(C)[C@@H]3CC[C@@H]1[C@]2(C)CC[C@H](OC)C1(C)C MRNPHCMRIQYRFU-UWAWSDATSA-N 0.000 description 1
- BRQBMPGDACUHNR-UHFFFAOYSA-N Cylindrin Natural products COC1CCC2(C)C(CCC3C2=CCC4(C)C5CCC(C(C)C)C5CCC34C)C1(C)C BRQBMPGDACUHNR-UHFFFAOYSA-N 0.000 description 1
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 description 1
- 206010013952 Dysphonia Diseases 0.000 description 1
- DCEFCUHVANGEOE-UHFFFAOYSA-N Ecdysterone Natural products CC(CC(C)(C)O)C(O)C(C)(O)C1CCC2(O)C3=CC(=O)C4CC(O)C(O)CC4(C)C3CCC12C DCEFCUHVANGEOE-UHFFFAOYSA-N 0.000 description 1
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 description 1
- 229920002079 Ellagic acid Polymers 0.000 description 1
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 description 1
- 206010052369 Encephalitis lethargica Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- IOIGOIPHPUCFOB-UHFFFAOYSA-N Gentialutine Natural products C1=NC=C2C(C)C(O)CC2=C1 IOIGOIPHPUCFOB-UHFFFAOYSA-N 0.000 description 1
- 229920002581 Glucomannan Polymers 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- BTEISVKTSQLKST-UHFFFAOYSA-N Haliclonasterol Natural products CC(C=CC(C)C(C)(C)C)C1CCC2C3=CC=C4CC(O)CCC4(C)C3CCC12C BTEISVKTSQLKST-UHFFFAOYSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000010496 Heart Arrest Diseases 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 206010019755 Hepatitis chronic active Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 208000009889 Herpes Simplex Diseases 0.000 description 1
- 208000010473 Hoarseness Diseases 0.000 description 1
- OVSQVDMCBVZWGM-SJWGPRHPSA-N Hyperin Natural products O[C@H]1[C@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-SJWGPRHPSA-N 0.000 description 1
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 description 1
- 206010020741 Hyperpyrexia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- HKODIGSRFALUTA-ZJQCNOOHSA-N Integerrimine Natural products CC=C1C[C@H](C)[C@@](C)(O)C(=O)OCC2=CCN3CC[C@@H](OC1=O)[C@H]23 HKODIGSRFALUTA-ZJQCNOOHSA-N 0.000 description 1
- RNKZFOIQKCQOAQ-UHFFFAOYSA-N Isopimpinellin Natural products COC1CC(=O)Oc2c(OC)c3occc3cc12 RNKZFOIQKCQOAQ-UHFFFAOYSA-N 0.000 description 1
- VFXXNAVZODKBIW-SIEBBUFOSA-N Isoplumericin Chemical compound COC(=O)C([C@@H](C=C1)[C@H]23)=CO[C@@H]2O[C@@H]\2[C@]13OC(=O)C/2=C\C VFXXNAVZODKBIW-SIEBBUFOSA-N 0.000 description 1
- GQODBWLKUWYOFX-UHFFFAOYSA-N Isorhamnetin Natural products C1=C(O)C(C)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 GQODBWLKUWYOFX-UHFFFAOYSA-N 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- YFVGIJBUXMQFOF-SAXLCNSLSA-N Linarin Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@H](Oc2cc(O)c3C(=O)C=C(c4ccc(OC)cc4)Oc3c2)O1)[C@H]1[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O1 YFVGIJBUXMQFOF-SAXLCNSLSA-N 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 208000032923 Lobar pneumonia Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- RCQBVCISWCRYBO-SOYDKUNTSA-N Lupenone Natural products CC(=C)[C@@H]1CC[C@]2(C)CC[C@@H]3[C@H](CC[C@H]4[C@@]3(C)CC[C@H]5C(C)(C)C(=O)CC[C@]45C)[C@@H]12 RCQBVCISWCRYBO-SOYDKUNTSA-N 0.000 description 1
- GRBHNQFQFHLCHO-UHFFFAOYSA-N Lupenonq Natural products C1CC(=O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C GRBHNQFQFHLCHO-UHFFFAOYSA-N 0.000 description 1
- 240000005819 Magnolia denudata Species 0.000 description 1
- 235000016094 Magnolia denudata Nutrition 0.000 description 1
- 241000192041 Micrococcus Species 0.000 description 1
- 208000005647 Mumps Diseases 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010029155 Nephropathy toxic Diseases 0.000 description 1
- FQTLCLSUCSAZDY-ATGUSINASA-N Nerolidol Chemical compound CC(C)=CCC\C(C)=C\CC[C@](C)(O)C=C FQTLCLSUCSAZDY-ATGUSINASA-N 0.000 description 1
- YLZYAUCOYZKLMA-UHFFFAOYSA-N O-Methyl-maackiain Natural products O1C2=CC=3OCOC=3C=C2C2C1C1=CC=C(OC)C=C1OC2 YLZYAUCOYZKLMA-UHFFFAOYSA-N 0.000 description 1
- PTPHDVKWAYIFRX-UHFFFAOYSA-N Palmatine Natural products C1C2=C(OC)C(OC)=CC=C2C=C2N1CCC1=C2C=C(OC)C(OC)=C1 PTPHDVKWAYIFRX-UHFFFAOYSA-N 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 241000009328 Perro Species 0.000 description 1
- AOPMSFXOYJXDNJ-IRFSQMTFSA-N Plumieride Chemical compound O([C@@H]1OC=C([C@@H]2[C@H]1[C@]1(C=C(C(=O)O1)[C@H](C)O)C=C2)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O AOPMSFXOYJXDNJ-IRFSQMTFSA-N 0.000 description 1
- SWQUJDQGKHRBEP-UHFFFAOYSA-N Plumieride Natural products COC(=O)C1=CCC(OC2OC(CO)C(O)C(O)C2O)C3C1C=CC34OC(=O)C(=C4)C(C)O SWQUJDQGKHRBEP-UHFFFAOYSA-N 0.000 description 1
- GTRPODKMSBFDOI-UHFFFAOYSA-N Protopine Natural products CN1Cc2c3OCOc3ccc2C4C1Cc5cc6OCOc6cc5C4=O GTRPODKMSBFDOI-UHFFFAOYSA-N 0.000 description 1
- ZAALQOFZFANFTF-UHFFFAOYSA-N Pseudoprotipine Natural products C1=C2C(=O)CC3=CC=4OCOC=4C=C3CN(C)CCC2=CC2=C1OCO2 ZAALQOFZFANFTF-UHFFFAOYSA-N 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- SLEPYIDGMPDTFO-UHFFFAOYSA-N Pterocarpin Natural products COc1ccc2C3Oc4c5OCOc5ccc4C3COc2c1 SLEPYIDGMPDTFO-UHFFFAOYSA-N 0.000 description 1
- AAWZDTNXLSGCEK-ZHQZDSKASA-N Quinic acid Natural products O[C@H]1CC(O)(C(O)=O)C[C@H](O)C1O AAWZDTNXLSGCEK-ZHQZDSKASA-N 0.000 description 1
- 208000004756 Respiratory Insufficiency Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- ZONYXWQDUYMKFB-UHFFFAOYSA-N SJ000286395 Natural products O1C2=CC=CC=C2C(=O)CC1C1=CC=CC=C1 ZONYXWQDUYMKFB-UHFFFAOYSA-N 0.000 description 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 241000607762 Shigella flexneri Species 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000010513 Stupor Diseases 0.000 description 1
- AEQDJSLRWYMAQI-UHFFFAOYSA-N Tetrahydropalmatine Natural products C1CN2CC(C(=C(OC)C=C3)OC)=C3CC2C2=C1C=C(OC)C(OC)=C2 AEQDJSLRWYMAQI-UHFFFAOYSA-N 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- 208000007074 Trichomonas Vaginitis Diseases 0.000 description 1
- 208000025206 Trichomonas vaginitis urogenital infection Diseases 0.000 description 1
- 241000223238 Trichophyton Species 0.000 description 1
- VGSYCWGXBYZLLE-QEEQPWONSA-N Trifolirhizin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C([C@H]2[C@H](C3=CC=4OCOC=4C=C3O2)CO2)C2=C1 VGSYCWGXBYZLLE-QEEQPWONSA-N 0.000 description 1
- FCRUGSNPZLERNO-UHFFFAOYSA-N Trifolirhizin Natural products OCC1OC(Oc2ccc3C4Oc5c6OCOc6ccc5C4COc3c2)C(O)C(O)C1O FCRUGSNPZLERNO-UHFFFAOYSA-N 0.000 description 1
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 206010046814 Uterine prolapse Diseases 0.000 description 1
- 206010047295 Ventricular hypertrophy Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 206010047799 Vulvovaginitis trichomonal Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- KGEKLUUHTZCSIP-HOSYDEDBSA-N [(1s,4s,6r)-1,7,7-trimethyl-6-bicyclo[2.2.1]heptanyl] acetate Chemical compound C1C[C@]2(C)[C@H](OC(=O)C)C[C@H]1C2(C)C KGEKLUUHTZCSIP-HOSYDEDBSA-N 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- ZHQQRIUYLMXDPP-ZETCQYMHSA-N actinidine Chemical compound C1=NC=C(C)C2=C1[C@@H](C)CC2 ZHQQRIUYLMXDPP-ZETCQYMHSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 201000009840 acute diarrhea Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 231100000354 acute hepatitis Toxicity 0.000 description 1
- 206010001093 acute tonsillitis Diseases 0.000 description 1
- FSLPMRQHCOLESF-UHFFFAOYSA-N alpha-amyrenol Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C)C(C)C5C4=CCC3C21C FSLPMRQHCOLESF-UHFFFAOYSA-N 0.000 description 1
- 229930014345 anabasine Natural products 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- 230000001088 anti-asthma Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000003509 anti-fertility effect Effects 0.000 description 1
- 230000001716 anti-fugal effect Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000002158 anti-implantation Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000000118 anti-neoplastic effect Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 230000001572 anti-trichomonad Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- JFSHUTJDVKUMTJ-QHPUVITPSA-N beta-amyrin Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C JFSHUTJDVKUMTJ-QHPUVITPSA-N 0.000 description 1
- QQFMRPIKDLHLKB-UHFFFAOYSA-N beta-amyrin Natural products CC1C2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C)CCC1(C)C QQFMRPIKDLHLKB-UHFFFAOYSA-N 0.000 description 1
- PDNLMONKODEGSE-UHFFFAOYSA-N beta-amyrin acetate Natural products CC(=O)OC1CCC2(C)C(CCC3(C)C4(C)CCC5(C)CCC(C)(C)CC5C4=CCC23C)C1(C)C PDNLMONKODEGSE-UHFFFAOYSA-N 0.000 description 1
- NKDFYOWSKOHCCO-UHFFFAOYSA-N beta-ecdysone Natural products C1C(O)C(O)CC2(C)C(CCC3(C(C(C)(O)C(O)CCC(C)(O)C)CCC33O)C)C3=CC(=O)C21 NKDFYOWSKOHCCO-UHFFFAOYSA-N 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-N beta-methyl-butyric acid Natural products CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 description 1
- QXMNTPFFZFYQAI-IMDKZJJXSA-N beta-sitosterol 3-O-beta-D-glucopyranoside Natural products CC[C@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@H](CC[C@]4(C)[C@H]3CC[C@]12C)O[C@@H]5C[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)C(C)C QXMNTPFFZFYQAI-IMDKZJJXSA-N 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 208000006752 brain edema Diseases 0.000 description 1
- 235000004883 caffeic acid Nutrition 0.000 description 1
- 229940074360 caffeic acid Drugs 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- SGNBVLSWZMBQTH-PODYLUTMSA-N campesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](C)C(C)C)[C@@]1(C)CC2 SGNBVLSWZMBQTH-PODYLUTMSA-N 0.000 description 1
- 235000000431 campesterol Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 229940097217 cardiac glycoside Drugs 0.000 description 1
- 239000002368 cardiac glycoside Substances 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 230000003727 cerebral blood flow Effects 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 1
- 229960002471 cholic acid Drugs 0.000 description 1
- 235000019416 cholic acid Nutrition 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 1
- DQISGWRLCDLKJI-UHFFFAOYSA-N columbianetin Natural products C1=CC(=O)OC2=C(C(C(C(C)(O)C)O3)O)C3=CC=C21 DQISGWRLCDLKJI-UHFFFAOYSA-N 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- TUSDEZXZIZRFGC-XIGLUPEJSA-N corilagin Chemical compound O([C@H]1[C@H](O)[C@H]2OC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC[C@@H](O1)[C@H]2O)C(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-XIGLUPEJSA-N 0.000 description 1
- CPWYQGWOJMNXGJ-UHFFFAOYSA-N corilagin Natural products OC1C2COC(=O)c3c(O)c(O)c(O)c(O)c3c4c(O)c(O)c(O)c(O)c4C(=O)OC1C(O)C(OC(=O)c5cc(O)c(O)c(O)c5)O2 CPWYQGWOJMNXGJ-UHFFFAOYSA-N 0.000 description 1
- ZZIALNLLNHEQPJ-UHFFFAOYSA-N coumestrol Chemical class C1=C(O)C=CC2=C1OC(=O)C1=C2OC2=CC(O)=CC=C12 ZZIALNLLNHEQPJ-UHFFFAOYSA-N 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 108010089310 cylindrin Proteins 0.000 description 1
- NPJICTMALKLTFW-OFUAXYCQSA-N daucosterol Chemical compound O([C@@H]1CC2=CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CC[C@@H](CC)C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O NPJICTMALKLTFW-OFUAXYCQSA-N 0.000 description 1
- QDFKFNAHVGPRBL-UHFFFAOYSA-N daucosterol Natural products CCC(CCC(C)C1CCC2C1CCC3C2(C)CC=C4CC(CCC34C)OC5OC(CO)C(O)C(O)C5O)C(C)C QDFKFNAHVGPRBL-UHFFFAOYSA-N 0.000 description 1
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 1
- 230000037304 dermatophytes Effects 0.000 description 1
- CHWPMFMUQATVNK-ARYYTZDLSA-N dihydrosporogen AO-1 Natural products O[C@H]1[C@]2(C(C)=C)O[C@@H]2[C@]2(C)[C@@H](C)[C@H](O)CCC2=C1 CHWPMFMUQATVNK-ARYYTZDLSA-N 0.000 description 1
- 238000003113 dilution method Methods 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 229960002852 ellagic acid Drugs 0.000 description 1
- 235000004132 ellagic acid Nutrition 0.000 description 1
- AUVVAXYIELKVAI-CKBKHPSWSA-N emetine Chemical compound N1CCC2=CC(OC)=C(OC)C=C2[C@H]1C[C@H]1C[C@H]2C3=CC(OC)=C(OC)C=C3CCN2C[C@@H]1CC AUVVAXYIELKVAI-CKBKHPSWSA-N 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 229930003949 flavanone Natural products 0.000 description 1
- 150000002207 flavanone derivatives Chemical class 0.000 description 1
- 235000011981 flavanones Nutrition 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 229930182486 flavonoid glycoside Natural products 0.000 description 1
- 150000007955 flavonoid glycosides Chemical class 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 229940046240 glucomannan Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 239000000745 gonadal hormone Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-M hexanoate Chemical compound CCCCCC([O-])=O FUZZWVXGSFPDMH-UHFFFAOYSA-M 0.000 description 1
- PFOARMALXZGCHY-UHFFFAOYSA-N homoegonol Natural products C1=C(OC)C(OC)=CC=C1C1=CC2=CC(CCCO)=CC(OC)=C2O1 PFOARMALXZGCHY-UHFFFAOYSA-N 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- SIOMFBXUIJKTMF-UHFFFAOYSA-N hypoglauterpenic acid Natural products C1CC(O)C(C)(C)C2=CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C SIOMFBXUIJKTMF-UHFFFAOYSA-N 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 230000000622 irritating effect Effects 0.000 description 1
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- DFMAXQKDIGCMTL-UHFFFAOYSA-N isopimpinellin Chemical compound O1C(=O)C=CC2=C1C(OC)=C1OC=CC1=C2OC DFMAXQKDIGCMTL-UHFFFAOYSA-N 0.000 description 1
- IZQSVPBOUDKVDZ-UHFFFAOYSA-N isorhamnetin Chemical compound C1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 IZQSVPBOUDKVDZ-UHFFFAOYSA-N 0.000 description 1
- 235000008800 isorhamnetin Nutrition 0.000 description 1
- 235000008777 kaempferol Nutrition 0.000 description 1
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempherol Natural products C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000009438 liyan Substances 0.000 description 1
- GRBHNQFQFHLCHO-BHMAJAPKSA-N lupenone Chemical compound C1CC(=O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C GRBHNQFQFHLCHO-BHMAJAPKSA-N 0.000 description 1
- MQYXUWHLBZFQQO-QGTGJCAVSA-N lupeol Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C MQYXUWHLBZFQQO-QGTGJCAVSA-N 0.000 description 1
- PKGKOZOYXQMJNG-UHFFFAOYSA-N lupeol Natural products CC(=C)C1CC2C(C)(CCC3C4(C)CCC5C(C)(C)C(O)CCC5(C)C4CCC23C)C1 PKGKOZOYXQMJNG-UHFFFAOYSA-N 0.000 description 1
- 206010025135 lupus erythematosus Diseases 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- VGSYCWGXBYZLLE-UHFFFAOYSA-N maackiain 3-O-beta-D-galactopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2C(C3=CC=4OCOC=4C=C3O2)CO2)C2=C1 VGSYCWGXBYZLLE-UHFFFAOYSA-N 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- 208000010805 mumps infectious disease Diseases 0.000 description 1
- 210000000754 myometrium Anatomy 0.000 description 1
- QMGGMESMCJCABO-UHFFFAOYSA-N n-oxysophocarpine Chemical compound C12C3CCC[N+]2([O-])CCCC1CN1C3CC=CC1=O QMGGMESMCJCABO-UHFFFAOYSA-N 0.000 description 1
- 229920001206 natural gum Polymers 0.000 description 1
- 230000007694 nephrotoxicity Effects 0.000 description 1
- 231100000417 nephrotoxicity Toxicity 0.000 description 1
- WASNIKZYIWZQIP-AWEZNQCLSA-N nerolidol Natural products CC(=CCCC(=CCC[C@@H](O)C=C)C)C WASNIKZYIWZQIP-AWEZNQCLSA-N 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- BPAWXSVOAOLSRP-UHFFFAOYSA-N oleanane Natural products CCCCCCCCCCCCCCCC(=O)OC1CCC2(C)C(CCC3(C)C2CC=C4C5CC(C)(C)CCC5(C)C(O)CC34C)C1(C)C BPAWXSVOAOLSRP-UHFFFAOYSA-N 0.000 description 1
- 239000008601 oleoresin Substances 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- LPMXVESGRSUGHW-HBYQJFLCSA-N ouabain Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@@H]1C[C@@]2(O)CC[C@H]3[C@@]4(O)CC[C@H](C=5COC(=O)C=5)[C@@]4(C)C[C@@H](O)[C@@H]3[C@@]2(CO)[C@H](O)C1 LPMXVESGRSUGHW-HBYQJFLCSA-N 0.000 description 1
- 238000010422 painting Methods 0.000 description 1
- QUCQEUCGKKTEBI-UHFFFAOYSA-N palmatine Chemical compound COC1=CC=C2C=C(C3=C(C=C(C(=C3)OC)OC)CC3)[N+]3=CC2=C1OC QUCQEUCGKKTEBI-UHFFFAOYSA-N 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 229930015704 phenylpropanoid Natural products 0.000 description 1
- 229930006728 pinane Natural products 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- YLZYAUCOYZKLMA-SJCJKPOMSA-N pterocarpin Chemical compound O1C2=CC=3OCOC=3C=C2[C@H]2[C@@H]1C1=CC=C(OC)C=C1OC2 YLZYAUCOYZKLMA-SJCJKPOMSA-N 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- OVSQVDMCBVZWGM-DTGCRPNFSA-N quercetin 3-O-beta-D-galactopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-DTGCRPNFSA-N 0.000 description 1
- BBFYUPYFXSSMNV-UHFFFAOYSA-N quercetin-7-o-galactoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 BBFYUPYFXSSMNV-UHFFFAOYSA-N 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000006340 racemization Effects 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 201000004193 respiratory failure Diseases 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- SMQUZDBALVYZAC-UHFFFAOYSA-N salicylaldehyde Chemical class OC1=CC=CC=C1C=O SMQUZDBALVYZAC-UHFFFAOYSA-N 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 230000004799 sedative–hypnotic effect Effects 0.000 description 1
- HKODIGSRFALUTA-JTLQZVBZSA-N senecionine Chemical compound O1C(=O)C(=C/C)\C[C@@H](C)[C@@](C)(O)C(=O)OCC2=CCN3[C@H]2[C@H]1CC3 HKODIGSRFALUTA-JTLQZVBZSA-N 0.000 description 1
- OZPMZVHQAUHYCP-UHFFFAOYSA-N senecionine Natural products CC=C/1CC(C)C(C)(O)C(=O)OC2=CCN3CCC(OC1=O)C23 OZPMZVHQAUHYCP-UHFFFAOYSA-N 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 229930002534 steroid glycoside Natural products 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 1
- 229940032091 stigmasterol Drugs 0.000 description 1
- 235000016831 stigmasterol Nutrition 0.000 description 1
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- NUPTUAXNMUIMFS-MIHIQLSESA-N terchebin Chemical compound C([C@@H]1[C@H]2OC(=O)C=3[C@H]4C5=C(C(O[C@@H]([C@H](OC(=O)C=6C=C(O)C(O)=C(O)C=6)O1)[C@H]2OC(=O)C=1C=C(O)C(O)=C(O)C=1)=O)C=C(C(=C5OC4(O)C(O)(O)C(=O)C=3)O)O)OC(=O)C1=CC(O)=C(O)C(O)=C1 NUPTUAXNMUIMFS-MIHIQLSESA-N 0.000 description 1
- ULYXEEKCDUUGNM-UHFFFAOYSA-N terchebin Natural products Oc1cc(cc(O)c1O)C(=O)OCC2OC(OC(=O)c3cc(O)c(O)c(O)c3)C4OC(=O)C5CC(=O)C(=O)C(=O)C5c6c(O)c(O)c(O)cc6C(=O)OC2C4OC(=O)c7cc(O)c(O)c(O)c7 ULYXEEKCDUUGNM-UHFFFAOYSA-N 0.000 description 1
- 206010043554 thrombocytopenia Diseases 0.000 description 1
- 229940098465 tincture Drugs 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 201000002498 viral encephalitis Diseases 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 230000002618 waking effect Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
- A61K36/195—Strobilanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/234—Cnidium (snowparsley)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/24—Apocynaceae (Dogbane family), e.g. plumeria or periwinkle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
- A61K36/315—Isatis, e.g. Dyer's woad
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/483—Gleditsia (locust)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/486—Millettia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/69—Polygalaceae (Milkwort family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/738—Rosa (rose)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/754—Evodia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明涉及中药应用领域,特别公开了一种治疗血液透析患者血管通路局部硬结的中药。该一种治疗血液透析患者血管通路局部硬结的中药,以山慈菇,山豆根,千里光,翻白草,板蓝根,西青果,淡竹叶,鸡蛋花,布渣叶,三丫苦,八角枫,没药,延胡索,乳香,川牛膝,鸡血藤,月季花,黄花倒水莲,凌霄花,皂角刺和蛇床子为原料,按照一定的重量配比制备而成。本发明配制简单,吸收效果好,药效持续时间长,疗效显著,无副作用,安全性高,生产成本低,有利于病患及时减轻病状。
Description
(一)技术领域
本发明涉及中药应用领域,特别涉及一种治疗血液透析患者血管通路局部硬结的中药。
(二)背景技术
现代医学认为血管通路局部硬结是由于长期反复穿刺刺激造成受用血管腔壁受损,弹性减弱,局部组织纤维化而致硬结节瘢痕形成;中医学认为血液透析血管通路硬结属于中医“积聚”范畴;由于长期反复穿刺,络脉局部损伤,致络脉受阻,气血不畅,壅塞不通,日积月累形成积聚;气滞血瘀,脉络不和,积而成块是其主要病机;普通的治疗方法对治疗局部肿结有一定的效果,但是消肿比较缓慢,会影响血液透析正常进行。
(三)发明内容
本发明为了弥补现有技术的不足,提供了一种制备简单、疗效显著的治疗血液透析患者血管通路局部硬结的中药。
本发明是通过如下技术方案实现的:
一种治疗血液透析患者血管通路局部硬结的中药,由以下重量份数的原料制成:
山慈菇9-26克,山豆根10-25克,千里光9-28克,翻白草9-26克,板蓝根10-25克,西青果10-26克,淡竹叶9-25克,鸡蛋花10-26克,布渣叶10-21克,三丫苦6-25克,八角枫6-26克,没药10-26克,延胡索6-21克,乳香6-9克,川牛膝10-26克,鸡血藤9-26克,月季花16-35克,黄花倒水莲10-26克,凌霄花9-25克,皂角刺6-26克,蛇床子8-24克。
其优选的各原料的重量配比为:
山慈菇9克,山豆根10克,千里光9克,翻白草9克,板蓝根10克,西青果10克,淡竹叶9克,鸡蛋花10克,布渣叶10克,三丫苦6克,八角枫6克,没药10克,延胡索6克,乳香6克,川牛膝10克,鸡血藤9克,月季花16克,黄花倒水莲10克,凌霄花9克,皂角刺6克,蛇床子8克。
本发明所述中药为膏剂,将各原料清洗干净后,按常规方法制成膏剂,外敷于患处使用。
其中,各原料的药用性能如下所示:
山慈菇:性凉,味甘,微辛。归肝经、脾经。清热解毒、化痰散结。属清热药下属分类的清热解毒药。含葡萄甘露聚糖、杜鹃兰素I、杜鹃兰素II、对羟基苯甲醛等成分。
山豆根:性寒,味苦,有毒。归肺经、胃经。清热解毒、消肿利咽。属清热药下分类的清热解毒药。用治火毒蕴结、咽喉肿痛;外治诸热肿、毒虫咬伤。山豆根有抗肿瘤,增强免疫功能,抗溃疡,抑制高级中枢,兴奋低级中枢的作用,其中生物碱是其抗肿瘤的有效成分,对多种实验肿瘤有抑制作用。苦参碱还具体外抑菌作用。对兔、小鼠四氯化碳急性肝损伤和小鼠D-氨基半乳糖肝损伤均有保护作用;此外,苦参碱、氧化苦参碱、槐果碱等对大、小鼠5种关节炎动物模型有抗炎作用。山豆根碱及苦参碱等生物碱具解痉平喘作用。此外,苦参碱、氧化苦参碱、槐果碱及山豆根碱具抗心律失常作用;且具双向免疫功能。大剂量出现恶心、呕吐、腹痛、腹泻、抽搐、昏迷等,甚至呼吸衰竭至死,注意慎用。现代临床用于治疗咽喉肿痛、乙肝、慢性活动性肝炎、气管炎哮喘、乙脑等。主含生物碱和黄酮类成分,其他尚含苯丙素类、三萜及甾醇等。生物碱有苦参碱。氧化苦参碱、槐果碱、氧化槐果碱、山豆根碱等;黄酮有广豆根素、广豆根酮、紫檀素、三叶豆紫檀苷等。生物碱含量为1.37%~1.88%,苦参碱含量为0.039%、0.177%,氧化苦参碱含量为0.339%。1.336%。
千里光:性寒,味苦。归肝经、肺经。清热解毒、凉血消肿、清肝明目、杀虫止痛。属清热药下分类的清热解毒药。外用:煎水洗、捣敷或熬膏涂。用治风热感冒、流行性感冒、上呼吸道感染、急性扁桃体炎、咽喉肿痛、肺炎、大叶性肺炎等。煎剂具有抗菌、抑制钩端螺旋体生长、抗滴虫等作用,毒性小,煎剂灌服不能测出小鼠的半数致死量,对人阴道滴虫有一定的抑制作用。主要含千里光宁碱、千里光菲林碱、羽扇烯酮、齐墩果烷、β-谷固醇、胡萝卜苷、生物碱、对羟基苯乙酸、金丝桃苷、蒙花苷、齐墩果醇、槲皮素、消旋丁香脂素、大黄素、绿原酸、咖啡酸等成分。
翻白草:性平,味甘、微苦。归肝经、胃经、大肠经。清热解毒,止痢,止血。属清热药下属分类的清热解毒药。内服:煎汤,用量10~15g;或浸酒服。外用:适量,煎水熏洗或鲜品捣敷。用于湿热泻痢,痈肿疮毒,血热吐衄,便血,崩漏。
板蓝根:性寒,味苦。归心经、胃经。清热解毒、凉血利咽。属清热药下分类的清热解毒药。用治流感、流脑、乙脑、肺炎、丹毒、热毒发斑、神昏吐衄、咽肿、痄腮、疮疹等。含靛玉兰、靛蓝;并含有18种氨基酸,其中精氨酸的含量较高,氨基酸可能是板蓝根中的一个主要有效成分。对乙型肝炎病毒DNA有中度抑制作用;对金黄色葡萄球菌等多种致病菌以及钩端螺旋体均有抑制作用。
西青果:性平,味苦、微甘、涩。归肺经、大肠经。清热生津、利咽解毒。属清热药下属分类的清热解毒药。用治慢性咽喉炎、声音嘶哑、咽喉干燥。含鞣质20%~40%。其中主要成分为诃子酸,诃黎勒酸,并含鞣云实素,原诃子酸,鞣花酸及没食子酸等。此外,尚含毒八角酸,奎尼酸,糖类及氨基酸等。
淡竹叶:性寒,味甘、淡。归心经、胃经、小肠经。清热除烦、利尿。属清热药下属分类的清热泻火药。用治热病烦渴,小便赤涩淋痛,口舌生疮。不可治疗感冒、寒热头痛,烦躁胸闷,虚烦不眠。含三萜类和甾类物质芦竹素、白茅素、无羁萜、β-谷甾醇、豆甾醇、菜油甾醇、蒲公英甾醇等。通过家兔和猫的试验证明,淡竹叶有解热作用。利尿作用不强,但能明显增加尿中氯化物的含量。有升高血糖的作用。抑菌试验表明,水煎剂对金黄色葡萄球菌有一定的抑菌作用。
鸡蛋花:性甘、微苦,味平。归肺经、大肠经。清利湿热、清肠止泻、止咳化痰。属清热药下属的清热泻火药,水提液对兔、豚鼠、猫、小鼠有局部麻醉及非特异性的解痉作用。叶、茎中的褐色鸡蛋花素能抑制结核杆菌生长。用治湿热泄泻、痢疾腹痛。含a-松油醇、橙花叔醇等27种挥发性成分;鸡蛋花酸及苷类。鸡蛋花的茎皮含鸡蛋花苷;根含鸡蛋花素、异鸡蛋花素等;叶含山柰酚葡萄糖苷、槲皮素葡萄糖苷;乳汁中含羽扇豆醇及其乙酸酯。
布渣叶:味甘、淡,性微寒。归脾经、胃经。清热消滞、利湿退黄。属清热药下属中的清热泻火药,用治急性黄疸型肝炎,单纯性消化不良。水提物对离体豚鼠心脏有增加冠脉血流量作用,并能提高小鼠耐缺氧能力,对垂体后叶素所致的大鼠急性心肌缺血有保护作用,增加麻醉兔的脑血流量,降低血压与脑血管阻力。用治感冒、食滞、湿热食滞之脘腹胀痛、食少泄泻、湿热黄疸。含黄酮类成分,有异鼠李黄素、山柰黄素、槲皮黄素、5,6,4′-三羟基-3′-甲氧基黄酮-7-0-鼠李糖基葡萄糖苷、5,6,8,4′-四羟基黄酮-7-0-鼠李糖苷等。
三丫苦:性寒,味苦。归肝经、肺经、胃经。清热解毒、行气止痛、燥湿止痒。属清热药下分类的清热燥湿药。外用鲜叶捣烂敷或煎水洗患处。用治热病高热不退、咽喉肿痛、热毒疮肿、风湿痹痛、湿火骨痛、毒蛇咬伤、胃热痛、跌打肿痛。外用治肤湿热疮、皮肤瘙痒、痔疮。叶、根含生物碱。叶还含挥发油,油中主要成分为a-蒎烯和糠醛。
八角枫:味辛、苦,性温,有毒。归心经、肝经。祛风除湿、舒筋活络、散瘀止痛。属活血化瘀药下属中的活血止痛药。根煎剂或生物总碱,无论是静脉注射还是腹腔注射,均有明显的肌松作用,但不影响动物的清醒状态;一般引起肌松作用的剂量能增强离体家兔肠管的节律性收缩,并呈量效关系。小剂量对离体蛙心和兔心灌注时,可使收缩加强;加大剂量收缩减弱,甚至导致房室传递阻滞,但可自行恢复,还具抗菌作用,对心血管系统有抑制作用,增强肠、子宫平滑肌收缩,增强催眠药作用,抗早孕与抗着床,抗炎等,有肾毒性。含喜树次碱、消旋毒黎碱、β-香树脂醇己酸酯、三十烷醇、β-谷固醇,根、根皮中含八角枫碱,以须根中含量最多,达0.73%,分得的单体生物碱主要是dl-毒藜碱;还分离出吐根碱、N-甲基吐根酚碱,此外还有强心苷、酚类、氨基酸、有机酸、树脂等。
没药:性平,味辛、苦。归心经、肝经、脾经。散瘀定痛,消肿生肌。属活血化瘀药下分类的活血止痛药。用于胸痹心痛,胃脘疼痛,痛经经闭,产后瘀阻,癥瘕腹痛,风湿痹痛,跌打损伤,痈肿疮疡。与其他含油树脂的物质相似,没药(一般用酊剂)有某些局部刺激作用,可用于口腔洗剂中,也可用于胃肠无力时以兴奋肠蠕动。水浸剂用试管稀释法,1:2对堇色毛癣菌等皮肤真菌有抑制作用。所含挥发油对霉菌有轻度抑制作用。没药煎剂20mg/kg股动脉注射,可使麻醉狗股动脉血流量增加,血管阻力下降。
延胡索:性温,味辛、苦。归肝经、脾经。活血散瘀、理气止痛。属活血化瘀药下分类的活血止痛药。治疗全身各部气滞血瘀之痛、痛经、经闭、症瘕、产后瘀阻、跌扑损伤、疝气作痛。含20多种生物碱,如紫堇碱、原阿片碱、a-别隐品碱、黄连碱、巴马亭等。总碱的镇痛效价是吗啡的40%,总碱中以延胡索甲素、延胡素乙素、延胡素丑素的镇痛作用最为明显,其中延胡素乙素最强,延胡素丑素次之,延胡素甲素再次,较大用量对兔、犬、猴等均有镇静催眠作用,延胡索乙素有对抗中枢兴奋和增强中枢抑制作用;静注延胡素乙素可缩小脑梗塞范围、脑水肿及钙离子抑制。毒性:总碱LD50为2840毫克/千克,延胡素乙素LD50为146毫克/千克。
乳香:性温,味辛、苦。归心经、脾经、肝经。调气活血、定痛、消肿、生肌。属活血化瘀药下分类的活血止痛药。用量3~9克。用治气血瘀滞、心腹疼痛、痈疮肿毒、跌打损伤、风湿痹痛、痛经、产后瘀血刺痛。临床还用于治疗急性阑尾炎。含树脂60%~70%、树胶27%~35%、挥发油3%~8%。树脂主要成分为游离a,B.乳香脂酸、结合乳香脂酸等。挥发油为乳香镇痛的有效成分,主要为具镇痛作用的乙酸正辛酯,占挥发油总量的92.46%。以仪-蒎烯作指标成分,可将索马里乳香与埃塞俄比亚乳香及苏丹乳香鉴别开。
川牛膝:性平,味甘、微苦。归肝经、肾经。逐瘀通经、通利关节、利尿通淋。属活血化瘀药下属分类的活血调经药。用治风湿性腰膝疼痛、脚痿筋挛、血淋、尿淋、尿血、妇女经闭、瘕瘕。含生物碱、β-蜕皮甾酮等甾体类化合物。动物试验表明,水煎剂及流浸膏能使实验动物子宫强烈收缩,并有抗生育作用及一定活血作用。蜕皮甾酮灌胃可促进大鼠胆汁分泌,使胆酸及胆红素含量增加,胆固醇含量降低;并能抑制WR-1339所致大鼠高胆固醇血症及高甘油三酯症,对兔实验性动脉硬化也有抑制作用。
鸡血藤:性温,味苦、甘。归肝经、肾经。补血、活血、通络,具抗炎作用。属活血化瘀药下分类的活血调经药。用治月经不调、血虚萎黄、麻木瘫痪、风湿痹痛。含有多种异黄酮、二氢黄酮、查耳酮、拟雌内酯类、三萜类和甾醇等成分。水煎剂对离体及在体蟾蜍心脏有轻度抑制作用;也能增加壮年兔血细胞作用,升高其血红蛋白;能加强子宫的节律性收缩。有调节血脂、抗动脉粥样硬化病变作用。用鸡血藤糖浆10~20毫升,每日3次,治疗贫血疗效好。用以鸡血藤为主药的"升白冲剂"或″鸡甲升白汤"治疗白细胞减少症有较好的临床疗效。也可治疗风湿性关节炎、红斑性狼疮、血小板减少、急性泄泻等症。
月季花:性温,味甘。归肝经。活血调经、疏肝解郁。属活血化瘀药下属分类的活血调经药。用治肝气郁结而致的月经不调、痛经、经闭、胸腹胀痛、跌打损伤、血瘀肿痛、痈疽肿毒及瘰疬等。不宜久煎;用量不宜过大,过量可引起腹痛,多服久服可引起便溏腹泻。孕妇亦当慎用;主要含挥发油,大部分为萜醇类化合物。有较强的抗真菌作用,已分离出其抗真菌的有效成分是没食子酸。
黄花倒水莲:性平,味甘、微苦。归肝经、肾经、脾经。益气养血、健脾利湿、活血调经。属活血化瘀药下属分类的活血调经药。用治病后体虚、腰膝酸痛、脾虚湿盛之水肿、带下、血虚血瘀之月经不调、跌打肿痛。含皂苷、多糖等成分。10%与30%水煎液能抗垂体后叶素引起的家兔急性心肌缺血,降低豚鼠离体心脏冠脉阻力,增加冠脉流量;对大鼠肾型高血压具降压作用,并对其心室肥厚具有保护作用。多糖类成分能提高正常小鼠的免疫力,并具抗应激作用。此外,对乙肝病毒体外具抑制作用。临床上用治高脂血症,具一定的疗效。现代临床上有用治子宫下垂,急、慢性肝炎等症。
凌霄花:性寒,味甘、酸。归肝经、心包经。行气祛瘀、凉血祛风。属活血化瘀药下属分类的活血调经药。用治血瘀经闭、癥瘕、跌打损伤、血瘀崩漏、难产、痫疾、瘾疹、湿癣等。含黄酮类、有机酸、猕猴桃碱、草苁蓉碱等。对福氏痢疾杆菌和伤寒杆菌有抑制作用。
皂角刺:性温,味辛。归肝经、胃经。消肿托毒、排脓、杀虫。属杀虫止痒药。水煎服,外用适量,醋蒸取汁涂患处。用治痈疽初起或脓成不溃;外治疥癣麻风。痈疽肿毒,脓未成者常与穿山甲同用。含黄酮苷、酚类、氨基酸等成分。煎剂用平板打洞法对金黄色葡萄球菌和卡他球菌有抑制作用;水浸剂对肉瘤-180的抑制率为32.8%。
蛇床子:性温,味辛、苦。归肾经。温肾壮阳、燥湿、祛风、杀虫。属杀虫止痒药。水煎服或入丸散。外用:煎水熏洗,或研末撒、调敷。用治阳痿、宫冷、寒湿带下、湿痹腰痛,外治外阴湿疹、妇人阴痒、滴虫性阴道炎。具性激素样、平喘、镇静、局部麻醉和抗微生物等作用。含挥发油,主要成分为蒎稀、异缬草酸龙脑酯、欧芹酚甲醚、二氢欧山芹醇、佛手柑内酯、蛇床子素、异茴芹素等。
本发明以活血散瘀,理气止痛为治则,多种药材组合协同,主要用于散结解毒,清热降火,利水消肿,收敛防腐,通络镇痛,宽中理气,调节脏腑阴阳,疏通气血,对血液透析患者血管通路局部硬结有显著的治疗作用。
临床观察:
(1)临床资料
本发明人于2010年至今,对453例血液透析患者血管通路局部硬结患者进行临床观察治疗。
(2)治疗方法
将制得的药膏外敷于患处,每日二到三次。根据患者病情轻重计算治疗时间,轻度患者敷用5~7天左右,重病患者连敷10~15天即可痊愈。
(3)疗效判定标准
疗效标准参照《中医病症判断疗效标准》中有关疗效标准。
治愈:临床症状全部消失,实验室检查正常。
显效:临床症状基本消失,试验室检查各相关指标接近正常水平。
有效:临床症状减轻,试验室检查各相关指标有所改善,体征有改善。
无效:临床症状无明显好转或加重。
(4)临床结果
临床治愈370例(81.68%),显效59例(13.02%),有效21例(4.64%),无效3例(0.66%),总有效率为99.34%。
本发明配制简单,吸收效果好,药效持续时间长,疗效显著,无副作用,安全性高,生产成本低,有利于病患及时减轻病状。
(四)具体实施方式
实施例1:
取山慈菇9克,山豆根10克,千里光9克,翻白草9克,板蓝根10克,西青果10克,淡竹叶9克,鸡蛋花10克,布渣叶10克,三丫苦6克,八角枫6克,没药10克,延胡索6克,乳香6克,川牛膝10克,鸡血藤9克,月季花16克,黄花倒水莲10克,凌霄花9克,皂角刺6克,蛇床子8克,将上述原料清洗干净,用常规方法制成膏剂。
用法用量:将制得的药膏外敷于患处,每日二到三次。
实施例2:
取山慈菇26克,山豆根25克,千里光28克,翻白草26克,板蓝根25克,西青果26克,淡竹叶25克,鸡蛋花26克,布渣叶21克,三丫苦25克,八角枫26克,没药26克,延胡索21克,乳香9克,川牛膝26克,鸡血藤26克,月季花35克,黄花倒水莲26克,凌霄花25克,皂角刺26克,蛇床子24克,将上述原料清洗干净,用常规方法制成膏剂。
用法用量:将制得的药膏外敷于患处,每日二到三次。
实施例3:
取山慈菇16克,山豆根15克,千里光21克,翻白草18克,板蓝根17克,西青果19克,淡竹叶21克,鸡蛋花20克,布渣叶16克,三丫苦19克,八角枫21克,没药18克,延胡索16克,乳香7克,川牛膝20克,鸡血藤21克,月季花25克,黄花倒水莲18克,凌霄花21克,皂角刺20克,蛇床子19克,将上述原料清洗干净,用常规方法制成膏剂。
用法用量:将制得的药膏外敷于患处,每日二到三次。
Claims (3)
1.一种治疗血液透析患者血管通路局部硬结的中药,其特征为,由以下重量份数的原料制成:山慈菇9-26克,山豆根10-25克,千里光9-28克,翻白草9-26克,板蓝根10-25克,西青果10-26克,淡竹叶9-25克,鸡蛋花10-26克,布渣叶10-21克,三丫苦6-25克,八角枫6-26克,没药10-26克,延胡索6-21克,乳香6-9克,川牛膝10-26克,鸡血藤9-26克,月季花16-35克,黄花倒水莲10-26克,凌霄花9-25克,皂角刺6-26克,蛇床子8-24克。
2.根据权利要求1所述的一种治疗血液透析患者血管通路局部硬结的中药,其特征为,由以下重量份数的原料制成:山慈菇9克,山豆根10克,千里光9克,翻白草9克,板蓝根10克,西青果10克,淡竹叶9克,鸡蛋花10克,布渣叶10克,三丫苦6克,八角枫6克,没药10克,延胡索6克,乳香6克,川牛膝10克,鸡血藤9克,月季花16克,黄花倒水莲10克,凌霄花9克,皂角刺6克,蛇床子8克。
3.根据权利要求1所述的一种治疗血液透析患者血管通路局部硬结的中药,其特征在于:所述中药为膏剂。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610207862.0A CN105770538A (zh) | 2016-04-06 | 2016-04-06 | 一种治疗血液透析患者血管通路局部硬结的中药 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610207862.0A CN105770538A (zh) | 2016-04-06 | 2016-04-06 | 一种治疗血液透析患者血管通路局部硬结的中药 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105770538A true CN105770538A (zh) | 2016-07-20 |
Family
ID=56395728
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610207862.0A Pending CN105770538A (zh) | 2016-04-06 | 2016-04-06 | 一种治疗血液透析患者血管通路局部硬结的中药 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105770538A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106728948A (zh) * | 2017-01-23 | 2017-05-31 | 迟瑞玲 | 一种治疗血透血管通路局部硬结的中药组合物 |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103393962A (zh) * | 2013-07-29 | 2013-11-20 | 济南伟传信息技术有限公司 | 一种治疗花斑癣的外用中药 |
CN103566242A (zh) * | 2013-11-12 | 2014-02-12 | 济南伟传信息技术有限公司 | 一种治疗扁平疣的中药膏 |
CN104435577A (zh) * | 2014-12-02 | 2015-03-25 | 王黎明 | 一种治疗腰椎间盘突出的中药膏药 |
CN104547936A (zh) * | 2015-01-15 | 2015-04-29 | 郭先义 | 一种治疗血液透析患者血管通路局部硬结的中药 |
CN104840838A (zh) * | 2015-05-26 | 2015-08-19 | 李金戈 | 一种治疗骨科扭挫伤的中药膏剂 |
CN104906541A (zh) * | 2015-06-12 | 2015-09-16 | 马志刚 | 一种烧伤护理用药膏 |
CN104940591A (zh) * | 2015-07-10 | 2015-09-30 | 李海亮 | 一种治疗腰椎间盘突出的膏药 |
CN104958700A (zh) * | 2015-07-14 | 2015-10-07 | 张秀琴 | 一种治疗血管通路局部硬结的中药 |
CN105232849A (zh) * | 2015-11-09 | 2016-01-13 | 李承存 | 一种治疗烧伤的膏药 |
CN105362944A (zh) * | 2015-12-08 | 2016-03-02 | 张昆 | 一种治疗骨科扭挫伤的中药膏剂 |
CN105412371A (zh) * | 2015-12-07 | 2016-03-23 | 吴兴玉 | 一种治疗软组织损伤的外用药 |
-
2016
- 2016-04-06 CN CN201610207862.0A patent/CN105770538A/zh active Pending
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103393962A (zh) * | 2013-07-29 | 2013-11-20 | 济南伟传信息技术有限公司 | 一种治疗花斑癣的外用中药 |
CN103566242A (zh) * | 2013-11-12 | 2014-02-12 | 济南伟传信息技术有限公司 | 一种治疗扁平疣的中药膏 |
CN104435577A (zh) * | 2014-12-02 | 2015-03-25 | 王黎明 | 一种治疗腰椎间盘突出的中药膏药 |
CN104547936A (zh) * | 2015-01-15 | 2015-04-29 | 郭先义 | 一种治疗血液透析患者血管通路局部硬结的中药 |
CN104840838A (zh) * | 2015-05-26 | 2015-08-19 | 李金戈 | 一种治疗骨科扭挫伤的中药膏剂 |
CN104906541A (zh) * | 2015-06-12 | 2015-09-16 | 马志刚 | 一种烧伤护理用药膏 |
CN104940591A (zh) * | 2015-07-10 | 2015-09-30 | 李海亮 | 一种治疗腰椎间盘突出的膏药 |
CN104958700A (zh) * | 2015-07-14 | 2015-10-07 | 张秀琴 | 一种治疗血管通路局部硬结的中药 |
CN105232849A (zh) * | 2015-11-09 | 2016-01-13 | 李承存 | 一种治疗烧伤的膏药 |
CN105412371A (zh) * | 2015-12-07 | 2016-03-23 | 吴兴玉 | 一种治疗软组织损伤的外用药 |
CN105362944A (zh) * | 2015-12-08 | 2016-03-02 | 张昆 | 一种治疗骨科扭挫伤的中药膏剂 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106728948A (zh) * | 2017-01-23 | 2017-05-31 | 迟瑞玲 | 一种治疗血透血管通路局部硬结的中药组合物 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102205026B (zh) | 一种治疗小儿慢性鼻窦炎的中药组合物及其制备方法 | |
CN104173937A (zh) | 一种疏肝利胆的中药组合物及其应用 | |
CN102772737A (zh) | 用于治疗肝硬化纤维化的中药组合物及其制备方法 | |
CN105381352A (zh) | 一种治疗妇科炎症的外用中药洗液 | |
CN104436131A (zh) | 一种用于治疗猪痢疾的药物组合物及其制备方法 | |
CN106266885A (zh) | 一种检验科用中药消毒液 | |
CN101244215A (zh) | 治疗肝炎的药物 | |
CN109820943B (zh) | 一种治疗痛风的壮药制剂及其制备方法 | |
CN101342249B (zh) | 一种治疗乙肝的中药制剂及其制备方法 | |
CN101129923A (zh) | 一种治疗子宫内膜炎的中药制剂 | |
CN113209194B (zh) | 一种治疗慢性胃炎的组合物及其制备方法和应用 | |
CN104547902A (zh) | 中药制剂用于制备治疗慢性肠炎、阑尾炎药物中的用途 | |
CN105770538A (zh) | 一种治疗血液透析患者血管通路局部硬结的中药 | |
CN104984184A (zh) | 一种治疗小儿阑尾脓肿的药物组合物及其制备方法 | |
CN105169278A (zh) | 一种保肝利胆的蒲公英口服液及其制备方法 | |
CN100348241C (zh) | 治疗慢性前列腺炎的药物及其制备方法 | |
CN103182058A (zh) | 一种治疗慢性盆腔炎的药物及其制备方法 | |
CN103585366A (zh) | 一种治疗缺血性高脂血症的药物及其制备方法 | |
CN101239136A (zh) | 一种用于治疗风湿的药剂 | |
CN107007697A (zh) | 一种治疗盆腔炎或前列腺炎的中药组合物及其制剂 | |
CN103611098B (zh) | 一种治疗皮肤瘙痒的中药 | |
CN104225094A (zh) | 治疗贝赫切特综合征的中药制剂 | |
CN104800667A (zh) | 一种治疗阑尾炎的中药剂及制备方法 | |
CN112439036A (zh) | 一种中药组合物在制备治疗前列腺增生药物中的应用 | |
CN105194129A (zh) | 一种医治尿道炎的组合物及制法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160720 |